Search clinical trials for: Toremifene
Total 0 results
Nothing found
Sponsors and Collaborators
- Institute for Intelligent Systems and Robotics
- The Consortium to Alleviate PTSD
- AshtaYoga, LLC
- Center for Healthy Aging, University of Copenhagen
- Institute for Follicular Lymphoma
- Erbe Elektromedizin GmbH
- Hospital of Sezana
- Quanzhou First Hospital Affiliated to Fujian Medical University
- Vital Solutions Swiss AG
- National Medical and Surgical Center named after N.I. Pirogov of the Ministry of Healthcare of the Russian Federation
- California Walnut Commission
- Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, China
- IASIO Hospital - General Clinic of Kallithea
- NotCo Brasil Distribuicao e Comercio de Produtos Alimenticios LTDA
- Køge Municipality
- S.G.S International Kft.
- Selva Therapeutics, Inc.
- Covalon Technologies Inc.
- General Hospital of Athens Elpis
- University Hospital Bispebjerg and Frederiksberg, Janne Pedersen, Statistician, PhD, Associate Professor
- View Full List
Medical Conditions
- Counterstrain
- Asthma and Allergic Rhinitis
- Dermatitis, Adverse Drug Reaction
- Type A Aortic Dissection
- Hepatic Enzymes
- Anal Intraepithelial Neoplasia 2
- Non-malignant Chronic Pain
- Appendix Tumor
- Non Alcoholic Fatty Liver
- Adenocarcinoma of Lung Stage IIIB
- Acquired Hypogonadotropic Hypogonadism
- Left Ventricular Ejection Fraction Less Then or Equal to 50percent
- Therapy Resistant Depression
- Febrile Convulsion
- Pediatric Progressive Low-grade Gliomas
- Elderly Residents
- Social Skill Training Group
- Hypno-breastfeeding Education
- Chronic Lymphocytic Leukemia (CLL)
- Rigid Spine Syndrome
- View Full List
Drug Interventions
- Naltrexone and bupropion SR
- Iohexol Inj 300 MG/ML
- High-dose loop diuretics
- Androgen-deprivation Therapy (ADT)
- Vehicle Foam with UVA and UVB and visible light irradiation
- MC-1101
- LX4211 800 mg
- ACP-204
- Olopatadine hydrochloride ophthalmic solution 0.7%)
- Jatenzo
- IBI318
- CAZ/AVI plus Aztreonam
- APD334
- P276-00
- Nystatin
- Omalizumab Injection
- Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
- RDEA3170 12 mg
- Ibudilast
- Ustekinumab
- View Full List
CROs by country
- Contract Research Organizations in China
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Gabon
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Malta
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Poland
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Singapore
- Contract Research Organizations in United Arab Emirates
- CRO list by country